Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$38.07 - $52.25 $418 - $574
11 Added 23.91%
57 $2,000
Q1 2024

Jun 11, 2024

SELL
$27.67 - $39.61 $387 - $554
-14 Reduced 23.33%
46 $1,000
Q4 2023

Feb 09, 2024

BUY
$30.6 - $43.78 $1,132 - $1,619
37 Added 160.87%
60 $1,000
Q3 2023

Nov 03, 2023

SELL
$39.39 - $58.12 $2,993 - $4,417
-76 Reduced 76.77%
23 $0
Q2 2023

Aug 04, 2023

BUY
$50.45 - $72.82 $4,136 - $5,971
82 Added 482.35%
99 $5,000
Q1 2023

May 11, 2023

BUY
$51.25 - $79.34 $871 - $1,348
17 New
17 $1,000
Q3 2022

Nov 07, 2022

BUY
$70.55 - $111.58 $40,848 - $64,604
579 New
579 $41,000
Q2 2022

Aug 01, 2022

SELL
$50.24 - $80.48 $1,808 - $2,897
-36 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$88.02 - $127.79 $3,168 - $4,600
36 New
36 $3,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.